Skip to main content

and
  1. Article

    Open Access

    Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT

    Christian Koenecke, Dirk-Jan Eikema, Sheree Hazelaar in Bone Marrow Transplantation (2022)

  2. No Access

    Article

    Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP

    Recently a new three-group clinical classification was reported by an International Consortium to stratify CMML patients with regard to prognosis. The groups were defined as follows: (1) Myelodysplastic (MD)-C...

    Francesco Onida, Giulia Sbianchi, Aleksandar Radujkovic in Bone Marrow Transplantation (2022)

  3. No Access

    Article

    Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMT

    Zinaida Peric, Christophe Peczynski, Emmanuelle Polge in Bone Marrow Transplantation (2021)

  4. Article

    Open Access

    Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation

    Allogeneic hematopoietic stem cell transplantation (alloSCT) carries the promise of cure for many malignant and non-malignant diseases of the lympho-hematopoietic system. Although outcome has improved consider...

    Thomas Luft, Peter Dreger, Aleksandar Radujkovic in Bone Marrow Transplantation (2021)

  5. No Access

    Article

    Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT

    Therapeutic management of patients with primary or secondary myelofibrosis (MF) who experience relapse or graft failure following allogeneic haematopoietic cell transplantation (allo-HCT) remains heterogeneous...

    Mitja Nabergoj, Katya Mauff, Marie Robin, Nicolaus Kröger in Bone Marrow Transplantation (2021)

  6. Article

    Open Access

    Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data

    Morbidity and mortality after allogeneic hematopoietic cell transplantation (alloHCT) are still essentially affected by reactivation of cytomegalovirus (CMV). We evaluated 80 seropositive patients transplanted...

    Patrick Derigs, Aleksandar Radujkovic, Maria-Luisa Schubert in Annals of Hematology (2021)

  7. Article

    Open Access

    Early bilirubinemia after allogeneic stem cell transplantation—an endothelial complication

    Hyperbilirubinemia occurs frequently after allogeneic stem cell transplantation. Causes include primary liver damage and endothelial complications as major contributors. Here, we have investigated the impact o...

    Hao Dai, Olaf Penack, Aleksandar Radujkovic, David Schult in Bone Marrow Transplantation (2021)

  8. Article

    Open Access

    Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality

    COVID-19 pneumonia and subsequent respiratory failure is causing an immense strain on intensive care units globally. Early prediction of severe disease enables clinicians to avoid acute respiratory distress sy...

    Adeline Lim, Aleksandar Radujkovic, Markus A. Weigand in Annals of Intensive Care (2021)

  9. Article

    Open Access

    Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD

    Chronic graft-versus-host disease (cGVHD) is a major cause of mortality and morbidity after allogeneic stem cell transplantation (alloSCT). The individual risk of severe cGVHD remains difficult to predict and ...

    Hao Dai, Sivaramakrishna P. Rachakonda, Olaf Penack, Igor W. Blau in Blood Cancer Journal (2021)

  10. No Access

    Article

    High leukemia-free survival after TBI-based conditioning and mycophenolate mofetil-containing immunosuppression in patients allografted for chronic myelomonocytic leukemia: a single-center experience

    This retrospective single-center analysis studied the impact of the conditioning and the graft-versus-host disease (GVHD) prophylaxis on outcome in unselected patients allografted for chronic myelomonocytic le...

    Aleksandar Radujkovic, Ute Hegenbart, Carsten Müller-Tidow in Annals of Hematology (2020)

  11. No Access

    Article

    EASIX and mortality after allogeneic stem cell transplantation

    Allogeneic stem cell transplantation (alloSCT) is an effective immunotherapy in patients with hematological malignancies. Endothelial dysfunction was linked to major complications after alloSCT. We asked the q...

    Thomas Luft, Axel Benner, Tobias Terzer, Sonata Jodele in Bone Marrow Transplantation (2020)

  12. Article

    Open Access

    EASIX for prediction of survival in lower-risk myelodysplastic syndromes

    Patients with myelodysplastic syndromes (MDS) are at risk of early death from cardiovascular complications due to the link between clonal hematopoiesis and endothelial dysfunction. EASIX (Endothelial Activatio...

    Almuth Merz, Ulrich Germing, Guido Kobbe, Jennifer Kaivers in Blood Cancer Journal (2019)

  13. No Access

    Article

    A prospective study on serum Cytokeratin (CK)-18 and CK18 fragments as biomarkers of acute hepato-intestinal GVHD

    Apoptotic intestinal crypt cells are pathognomonic of acute intestinal graft versus host disease (GVHD). Serum levels of the apoptotic degradation product cytokeratin-18 fragments (CK18F) were associated with ...

    Sandra Sauer, Johannes Hüsing, Jacek Hajda, Frank Neumann in Leukemia (2018)

  14. No Access

    Article

    In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemia

    The prognosis of patients with advanced-phase chronic myeloid leukemia (CML) remains dismal despite the availability of targeted therapies and allogeneic stem cell transplantation (allo-SCT). Increasing the an...

    Aleksandar Radujkovic, Thomas Luft, Peter Dreger in Cancer Chemotherapy and Pharmacology (2014)

  15. No Access

    Article

    Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells

    We investigated various combination treatment regimens employing nilotinib with established chemotherapeutic agents (daunorubicin, mitoxantrone, etoposide and cytarabine) in imatinib-sensitive and -resistant BCR-...

    Aleksandar Radujkovic, Stefan Fruehauf in Cancer Chemotherapy and Pharmacology (2010)

  16. No Access

    Article

    Normal-Tissue Radioprotection by Overexpression of the Copper-Zinc and Manganese Superoxide Dismutase Genes

    Protection of normal tissue against radiation-induced damage may increase the therapeutic ratio of radiotherapy. A promising strategy for testing this approach is gene therapy-mediated overexpression of the co...

    Marlon R. Veldwijk, Carsten Herskind, Leopold Sellner in Strahlentherapie und Onkologie (2009)